
About Diosma Life Sciences
Diosma Life Sciences is a Healthcare company. Manufacturing and exporting of pharmaceutical and nutraceutical products by Diosma Life Sciences in India. The company has 1 employees. Its Indian entity Diosma Lifesciences Private Limited reported revenue of βΉ4.55 Cr. Diosma Life Sciences offers products and services including Tablets and Capsules and Injectables. Its focus areas include Nutraceuticals, Export, International Distribution and Pharmaceuticals.
Company details
Diosma Life Sciences Is Recognized As A Manufacturer And Exporter Of High-quality Who-gmp Compliant Finished Dosage Forms, With Operations Based In Mumbai Since 2014. A Wide Spectrum Of Products, Including Tablets, Capsules, Syrups, Injectables, And Ointments, Is Produced In Facilities Located In Pollution-free Industrial Areas Of Uttarakhand. Commitment To Safety, Efficacy, And International Standards Is Demonstrated Through A Robust Quality Management System That Emphasizes Continuous Improvement And Ethical Practices. The Company Serves Domestic And Global Markets With A Focus On Pharmaceutical, Nutraceutical, And Ayurvedic Formulations, Ensuring Products Meet Global Requirements.
- Employees 1
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website diosmalifesciences.com
- Social Facebook
- Legal Name Diosma Life Sciences Pvt Ltd
- Date of Incorporation 04 Jun, 2014
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹4.55 Cr
FY 2025 · -2% YoY
- Indian entity net loss-₹63,187
FY 2025 · 0% margin
- Indian entity EBITDA₹14.7 Lakh
FY 2025 · 3% margin
- Employee Count1
Associated legal entities of Diosma Life Sciences
Diosma Life Sciences operates through Diosma Lifesciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Diosma Lifesciences Private Limited CIN U24233MH2014PTC255369 | Active | 04 Jun 2014 | Mumbai, Maharashtra | ₹4.6 Cr | 14 | 2 | View details |
Products & Services of Diosma Life Sciences
Diosma Life Sciences offers a comprehensive portfolio of products and services, including Tablets and Capsules and Injectables.
Tablets and capsules are produced as finished dosage forms that comply with WHO-GMP standards for various therapeutic applications.
Injectables are manufactured using advanced technology to ensure safety and efficacy in medical treatments.
Board of directors of Diosma Lifesciences Private Limited (Diosma Life Sciences)
Diosma Lifesciences Private Limited is the primary company behind Diosma Life Sciences. The board of Diosma Lifesciences Private Limited currently have 2 directors; the longest-serving is Girish Chandrapati Singh, appointed in 2014. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Girish Chandrapati Singh DIN 06843776 | Director | 04 Jun 2014 | 12 yrs 5 mo | Diosma Lifesciences Private Limited |
| Priyanka Girish Singh DIN 07590662 | Director | 16 Aug 2016 | 10 yrs 3 mo | Diosma Lifesciences Private Limited |
Financials of Diosma Life Sciences
Figures of Diosma Lifesciences Private Limited, the primary company behind Diosma Life Sciences, for FY 2025. Revenue was ₹4.55 Cr (-2% year on year). Net loss was -₹63,187 (0% margin). EBITDA was ₹14.7 Lakh (3% margin). Revenue has grown at a compounded annual rate of +8% over three years and +17% over five years.
- ₹4.55 CrRevenue · FY 2025 · -2% YoY
- -₹63,187Net loss · 0% margin
- ₹14.7 LakhEBITDA · 3% margin
- ₹1 LakhPaid-up capital
- 14Employees (provident fund records)
- +8%Revenue CAGR, 3 years
- +17%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Diosma Lifesciences Private Limited are on its company page.
Detailed financial statements for Diosma Life Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Diosma Life Sciences
Diosma Life Sciences has 1 employees.
The primary company behind Diosma Life Sciences, Diosma Lifesciences Private Limited, reported revenue of βΉ4.55 Cr for FY 2025, down 2% year on year.
Diosma Life Sciences Is Recognized As A Manufacturer And Exporter Of High-quality Who-gmp Compliant Finished Dosage Forms, With Operations Based In Mumbai Since 2014. A Wide Spectrum Of Products, Including Tablets, Capsules, Syrups, Injectables, And Ointments, Is Produced In Facilities Located In Pollution-free Industrial Areas Of Uttarakhand. Commitment To Safety, Efficacy, And International Standards Is Demonstrated Through A Robust Quality Management System That Emphasizes Continuous Improvement And Ethical Practices. The Company Serves Domestic And Global Markets With A Focus On Pharmaceutical, Nutraceutical, And Ayurvedic Formulations, Ensuring Products Meet Global Requirements.
Diosma Life Sciences offers Tablets and Capsules and Injectables.
Diosma Life Sciences operates through Diosma Lifesciences Private Limited.
The legal entities of Diosma Life Sciences currently have 2 directors, including Girish Chandrapati Singh, Priyanka Girish Singh.